SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001645113-20-000060
Filing Date
2020-04-27
Accepted
2020-04-27 16:43:10
Documents
10
Period of Report
2020-06-10
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A nvcr-20190522xdef14a.htm DEF 14A 1732730
2 GRAPHIC gml4ddpe4z1l000002a011.jpg GRAPHIC 2281
3 GRAPHIC gml4ddpe4z1l000003a011.jpg GRAPHIC 6896
4 GRAPHIC gml4ddpe4z1l000003a021.jpg GRAPHIC 6896
5 GRAPHIC gml4ddpe4z1l000004a011.jpg GRAPHIC 2281
6 GRAPHIC image1.jpg GRAPHIC 42274
7 GRAPHIC image2.jpg GRAPHIC 38619
8 GRAPHIC image3.jpg GRAPHIC 21538
9 GRAPHIC novocurelimited_p34065xprx.jpg GRAPHIC 197335
10 GRAPHIC novocurelimited_p34065xprx1.jpg GRAPHIC 232303
  Complete submission text file 0001645113-20-000060.txt   2493014
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37565 | Film No.: 20820674
SIC: 3841 Surgical & Medical Instruments & Apparatus